The gross classification of hepatocellular carcinoma: Usefulness of contrast-enhanced US

Journal of Clinical Ultrasound

Volumn 42, Issue 1, 2014, Pages 1-8

  Hatanaka, Kinuyo ^a   Minami, Yasunori ^a   Kudo, Masatoshi ^a   Inoue, Tatsuo ^a   Chung, Hobyung ^a   Haji, Seiji ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Contrast enhanced US; Hepatocellular carcinoma

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; FERRIC ION; IRON; OXIDE; PERFLUBUTANE;

AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; ECHOGRAPHY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; REPRODUCIBILITY;

AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; FERRIC COMPOUNDS; HUMANS; IRON; LIVER NEOPLASMS; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; OXIDES; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS;

EID: 84889683897     PISSN: 00912751     EISSN: 10970096     Source Type: Journal    
DOI: 10.1002/jcu.22080     Document Type: Article

References (32)

1. Kanai T, Hirohashi S, Upton MP, et al. Pathology of small hepatocellular carcinoma: a proposal for a new gross classification. Cancer 1987;60:81.
2. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 1989;19:98.
3. Hui AM, Takayama T, Sano K, et al. Predictive value of gross classification of hepatocellular carcinoma on recurrence and survival after hepatectomy. J Hepatol 2000;33:975.
4. Shirabe K, Aishima S, Taketomi A, et al. Prognostic importance of the gross classification of hepatocellular carcinoma in living donor-related liver transplantation. Br J Surg 2011;98:261.
5. Minami Y, Kudo M, Chung H, et al. Contrast harmonic sonography-guided radiofrequency ablation therapy versus B-mode sonography in hepatocellular carcinoma: prospective randomized controlled trial. AJR Am J Roentgenol 2007;188:489.
6. Solbiati L, Tonolini M, Cova L, et al. The role of contrast-enhanced ultrasound in the detection of focal liver lesions. Eur Radiol 2001;11:E15.
7. Konopke R, Bunk A, Kersting S. The role of contrast-enhanced ultrasound for focal liver lesion detection: an overview. Ultrasound Med Biol 2007;33:1515.
8. Furuse J, Nagase M, Ishii H, et al. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003;76:385.
9. Yanagisawa K, Moriyasu F, Miyahara T, et al. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med Biol 2007;33:318.
10. Sontum PC, Ostensen J, Dvrstad K, et al. Acoustic properties of NC100100 and their relation with the microbubble size distribution. Invest Radiol 1999;34:268.
11. Ramnarine KV, Kyriakopoulou K, Gordon P, et al. Improved characterisation of focal liver tumours: dynamic power Doppler imaging using NC100100 echo-enhancer. Eur J Ultrasound 2000;11:95.
12. Korenaga K, Korenaga M, Furukawa M, et al. Usefulness of Sonazoid contrast-enhanced ultrasonography for hepatocellular carcinoma: comparison with pathological diagnosis and superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2009;44:733.
13. Kudo M, Hatanaka K, Maekawa K. Defect reperfusion imaging, a newly developed novel technology using Sonazoid in treatment of hepatocellular carcinoma. J Med Ultrasound 2008;16:169.
14. Hatanaka K, Kudo M, Minami Y, et al. Differential diagnosis of hepatic tumors: value of contrast-enhanced harmonic sonography using the newly developed contrast agent, Sonazoid. Intervirology 2008;51:61.
15. Hatanaka K, Kudo M, Minami Y, et al. Sonazoid-enhanced ultrasonography for diagnosis of hepatic malignancies: comparison with contrast-enhanced CT. Oncology 2008;75:42.
16. Minami Y, Kudo M, Hatanaka K, et al. Radiofrequency ablation guided by contrast harmonic sonography using perfluorocarbon microbubbles (Sonazoid) for hepatic malignancies: an initial experience. Liver Int 2010;30:759.
17. Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas 1960;20:37.
18. Nakashima Y, Nakashima O, Tanaka M, et al. Portal vein invasion and intrahepatic micrometastasis in small hepatocellular carcinoma by gross type. Hepatol Res 2003;26:142.
19. Shimada M, Rikimaru T, Hamatsu T, et al. The role of macroscopic classification in nodular-type hepatocellular carcinoma. Am J Surg 2001;182:177.
20. Komatsu S, Murakami M, Fukumoto T, et al. Risk factors for survival and local recurrence after particle radiotherapy for single small hepatocellular carcinoma. Br J Surg 2011;98:558.
21. Roayaie S, Blume IN, Thung SN, et al. A system of classifying microvascular invasion to predict outcome after resection in patients with hepatocellular carcinoma. Gastroenterology 2009;137:850.
22. Inoue T, Kudo M, Watai R, et al. Differential diagnosis of nodular lesions in cirrhotic liver by post-vascular phase contrast-enhanced US with Levovist: comparison with superparamagnetic iron oxide magnetic resonance images. J Gastroenterol 2005;40:1139.
23. Inoue T, Kudo M, Maenishi O, et al. Value of liver parenchymal phase contrast-enhanced sonography to diagnose premalignant and borderline lesions and overt hepatocellular carcinoma. AJR Am J Roentgenol 2009;192:698.
24. Tanaka M, Nakashima O, Wada Y, et al. Pathomorphological study of Kupffer cells in hepatocellular carcinoma and hyperplastic nodular lesions in the liver. Hepatology 1996;24:807.
25. Minagawa M, Ikai I, Matsuyama Y, et al. Staging of hepatocellular carcinoma: assessment of the Japanese TNM and AJCC/UICC TNM systems in a cohort of 13, 772 patients in Japan. Ann Surg 2007;245:909.
26. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology 2010;78:S113.
27. Shiozawa K, Watanabe M, Takayama R, et al. Evaluation of local recurrence after treatment for hepatocellular carcinoma by contrast-enhanced ultrasonography using Sonazoid: comparison with dynamic computed tomography. J Clin Ultrasound 2010;38:182.
28. Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 2006;243:321.
29. Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg 2010;252:903.
30. Rossi S, Di Stasi M, Buscarini E, et al. Percutaneous radiofrequency interstitial thermal ablation in the treatment of small hepatocellular carcinoma. Cancer J Sci Am 1995;1:73.
31. Kim YS, Lee WJ, Rhim H, et al. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and<5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion. AJR Am J Roentgenol 2010;195:758.
32. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 2005;234:954.